- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
A screening for antimicrobial activities of Caribbean herbal remedies
© Luciano-Montalvo et al.; licensee BioMed Central Ltd. 2013
Received: 21 September 2012
Accepted: 31 May 2013
Published: 4 June 2013
The TRAMIL program aims to understand, validate and expand health practices based on the use of medicinal plants in the Caribbean, which is a “biodiversity hotspot” due to high species endemism, intense development pressure and habitat loss. The antibacterial activity was examined for thirteen plant species from several genera that were identified as a result of TRAMIL ethnopharmacological surveys or were reported in ethnobotanical accounts from Puerto Rico. The aim of this study was to validate the traditional use of these plant species for the treatment of bacterial infections, such as conjunctivitis, fever, otitis media and furuncles.
An agar disc diffusion assay was used to examine five bacterial strains that are associated with the reported infections, including Staphylococcus saprophyticus (ATCC 15305), S. aureus (ATCC 6341), Escherichia coli (ATCC 4157), Haemophilus influenzae (ATCC 8142), Pseudomonas aeruginosa (ATCC 7700) and Proteus vulgaris (ATCC 6896), as well as the fungus Candida albicans (ATCC 752). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined for each of the extracts that showed inhibitory activity.
The decoctions of Pityrogramma calomelanos, Tapeinochilus ananassae, and Syzygium jambos, as well as the juice of Gossypium barbadense, showed > 20% growth inhibition against several bacteria relative to the positive control, which was the antibiotic Streptomycin. Extracts with the best antimicrobial activities were S. jambos that showed MIC = 31 μg/mL and MBC = 1.0 mg/mL against P. vulgaris and T. ananassae that showed MIC = 15 μg/mL against S. aureus.
This report confirms the traditional use of P. calomelanos for the treatment of kidney infections that are associated with stones, as well as the antimicrobial and bactericidal effects of T. ananassae against P. vulgaris and S. saprophyticus and the effects of S. jambos against S. aureus and S. saprophyticus.
The plant-based formulations are a viable option that could be useful in reducing the side effects associated with conventional antibiotic treatment . Plant-based formulations would also increase the number of compounds that are used to limit infections  and might function synergistically with current therapies . Many reports have identified anti-bacterial properties of plants, but these studies have primarily been conducted in Asia . The Caribbean is one of the world’s centers of biodiversity and endemism identified as a tropical mountainous “biodiversity hotspot” because “high species endemism combines with proportionally extensive habitat loss” . Information regarding the use of herbal remedies in the Caribbean was obtained during TRAMIL (Traditional Medicines in the Islands) surveys. TRAMIL, which is a program of applied research focusing on popular medicine, was initiated in 1982 to understand, validate and expand primary health care practices based on the use of medicinal plants in the Caribbean. The TRAMIL program has a unique methodology that consists of ethnopharmacological surveys and bibliographic and experimental research. The TRAMIL program works to validate plant species, plant organs and methods of preparation that are recorded during TRAMIL surveys and that are used frequently, 20% or more, for a particular ailment but are not documented in the scientific literature. The scientific validation of traditional health practices is based on criteria of safety and efficacy [6, 7]. Moreover, TRAMIL organizes outreach activities (TRADIF) that are aimed at disseminating the results obtained from the efficacy and toxicity studies. Thus, the objectives and experience of TRAMIL in traditional Caribbean knowledge and the sustainable utilization of plants appear to be the best starting point to find interesting plants with antimicrobial potential.
In addition, plant species described in ethnobotanical accounts from Puerto Rico that are used to treat infections and as adjuvants for diabetes were included in this study [8, 9]. There is evidence that diabetic patients suffer from high bacteremia levels due to high blood sugar levels that weaken the patient’s immune system defenses  and increase the body’s vulnerability to bacterial infections [11, 12]. Consequently, the aim of this study was to validate the antimicrobial activity of herbal remedies that are used in the Caribbean to treat infections such as conjunctivitis, otitis media, kidney infections, and furuncles.
Plant collection and identification
Plant species recorded in ethnopharmacological/ethnobotanical surveys in the Caribbean that were examined for their antimicrobial and antifungal activities
Scientific name/(voucher specimen)
Plant parts used/Preparation form
Extracts yield (% w/w)
Concentration of extracts (mg/mL)
Concentration of extracts/disc (μg/μL)b
Cucurbitaceae Cucurbita moschata Duchesne (019344)
Dominican Republic/skin burns
Plantaginaceae Plantago major L. (019342)
Labiatae Plectranthus amboinicus (Lour.) Spreng. (019352)
Scrophulariaceae Capraria biflora L. (019353)
Guadalupe, Marie-Galante, Martinique, Tobago/conjunctivitis
Té péyi, paye, titi,
Malvaceae Abelmochus esculentus (L.) Moench (019662)
Dominican Republic/eye infections
Malvaceae Gossypium barbadense L. (019366)
leaves/decoction unripe fruit/juice
Malvaceae Hibiscus rosa-sinensis L. (019535)
Pteridaceae Pityrogramma calomelanos (L.) Link (019372)
Tobago/kidney stones or urolithiasis
stamp fern, egyptian secret
Aristolochiaceae Aristolochia trilobata L. (019609)
Commelinaceae Tradescantia spathacea Sw.c (019664)
Zingiberaceae Costus specious (J. König) Sm.c,d (019660)
caña amarga, insulina
Zingiberaceae Tapeinochilus ananassae K. Schum.d (019553)
Myrtaceae Syzygium jambos (L.) Alstond (019663)
Pomarrosa del río
Plant material and preparation of decoctions, juices and aqueous extracts
Decoctions were prepared by boiling 30 g of plant material in 100 mL of distilled water. After concentration to 15 mL, to lyophilize 3 × 5 mL replicates, the decoctions were filtered through cheesecloth, and freeze-dried using a Freezone 4.5 lyophilizer. Plant juices (3 × 5 mL replicates) were lyophilized after the plant part was crushed in a mortar and filtered through cheesecloth. The solids obtained after freeze-drying were re-dissolved in autoclaved water to known concentrations for antibacterial determination. The concentrations of the lyophilized extracts in mg/mL were calculated as the average of the total solids obtained per mL of lyophilized decoction or plant juice. The plant part, preparation form, concentration of the re-dissolved extracts and the extraction yields are reported in Table 1.
Whatman chromatography no 2 filter paper was used to prepare 6.3 mm paper discs that were incubated with 20 μL aliquots of the re-dissolved extracts from lyophilized decoctions or juices at their final concentration and at 25% and 50% dilutions, and air-dried for 2 hours, as described previously . The positive controls were Streptomycin (5 mg/mL) and Nystatin (50 mg/L) for the antibacterial and antifungal assays, respectively. Distilled water was used as a negative control. The concentration of the extracts in the paper discs is reported in Table 1.
Bacterial selection and culture
The Caribbean Herbal Pharmacopeia , which is published by the TRAMIL program, established the experimental models that are required to validate antimicrobial activity. In this case, the antimicrobial activity had to be confirmed for at least one case. For agents associated with bacterial conjunctivitis, TRAMIL requires in vitro susceptibility studies of Haemophilus influenzae, Streptococcus pneumonia or Staphylococcus aureus. For otitis media, TRAMIL recommends the analysis of the effects of herbal remedies against the Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa or Proteus vulgaris; the Gram-positive bacterium S. aureus; and the fungus Candida albicans. E. coli is the primary causal agent of urinary tract infections (UTIs) and accounts for > 75% of community-acquired UTIs in all age groups, whereas Staphylococcus saprophyticus accounts for 10% of total UTIs . Infections due to the presence of kidney stones are more commonly caused by urease-producing bacteria, such as S. aureus, Pseudomonas and Proteus. Finally, in the case of furuncle, which is an infection of the hair follicle, TRAMIL requires validation of antimicrobial activity against S. aureus.
The test organisms included the Gram-positive bacteria Staphylococcus saprophyticus (ATCC 15305) and Staphylococcus aureus (ATCC 6341); the Gram-negative bacteria Escherichia coli (ATCC 4157), Haemophilus influenzae (ATCC 8142), Pseudomonas aeruginosa (ATCC 7700), and Proteus vulgaris (ATCC 6896); and the fungus Candida albicans (ATCC 752). The bacteria were maintained at 4°C on tryptic soy agar (TSA), and C. albicans (ATCC 752) was maintained on potato dextrose agar (PDA) (Difco, NJ, USA) before use. H. influenza (ATCC 8142) was incubated in the presence of a Gas-Pac (Becton and Dickinson Co, NJ, USA) with 5% CO2.
Antimicrobial activity determination using the disc diffusion assay
The disc preparation was performed following the procedure outlined by the British Society for Antimicrobial Chemotherapy in their Methods for Antimicrobial Susceptibility Testing Version 7, January 2008 . A single bacterial colony was removed from a streak plate of Trypticase soy agar (TSA, BD Biosciences) and incubated in Luria broth (LB, Difco) overnight with shaking at 37°C. A bacterial suspension in 2 mL of distilled H2O was prepared and adjusted to a density of 0.5 McFarland units, which correspond to 1.5 × 108 CFU/mL. The suspension was then plated onto Mueller-Hinton agar (Difco), followed by disk deposition and incubation at 37°C for 20 hours. Growth inhibition was determined by measuring the diameter of the inhibition surrounding each disc. The relative inhibition was calculated for each extract and is represented as the percentage difference of inhibition between the positive control (antibiotic) and the extract. All of the experiments were performed in triplicate.
Minimum inhibitory concentration (MIC) determination
The MIC is defined as the lowest concentration of antimicrobial that can inhibit the visible growth of a microorganism after overnight incubation (British Society for Antimicrobial Chemotherapy). Extracts that showed inhibition in the disc diffusion assay were further analyzed according to the procedure of Velmonte et al. with some modifications . The bacterial species tested were S. saprophyticus (ATCC 15305), S. aureus (ATCC 6341), P. aeruginosa (ATCC 7700) and P. vulgaris (ATCC 6896). MIC was determined for the extracts of Syzygium jambos, Pityrogramma calomelanos, Tapeinochilus ananassae and Gossypium barbadense. Stock solutions of lyophilized aqueous extracts were serially diluted to obtain working solutions with concentrations ranging from 2.0 to 0.003 mg/mL. Wells in a sterile 96-well plate were inoculated with Luria Broth (LB) medium in the absence of bacteria (blank control sample), bacteria with medium (positive control sample), bacteria with medium and the extract dilutions (experimental samples), background control (samples consisting of medium with extract dilutions to eliminate background extract absorbance), and bacteria with Streptomycin at 10 mg/mL (negative control samples). Bacterial suspensions containing 5×104 CFU/mL of Staphylococcus aureus (ATCC 6341), Staphylococcus saprophyticus (ATCC 15305), Proteus vulgaris (ATCC 6896) or Pseudomonas aeruginosa (ATCC 7700) were added to each well. The 96-well plates were incubated at 37°C for 18–20 hours. The absorbance at 625 nm was measured for each plate using a microplate reader, and background-subtracted with the background of the control (bacteria and medium). Then, the absorbance of the extracts was compared to the absorbance of the positive and negative control (Streptomycin 10 mg/mL) wells. The MIC was the concentration in the wells that showed an absorbance lower to the control well and that also gave a p-value of 0.001 or less after statistical analysis.
Minimum bactericidal concentration (MBC) determination
The minimum bactericidal concentration (MBC) value is defined as the extract concentration at which no bacterial growth is observed in the agar nutrient plates, similar to the negative control Streptomycin (10 mg/mL). The effective concentration of the extracts in the experimental wells, as determined using the MIC assay, was used to inoculate LB plates using a sterile swab and incubated overnight at 37°C. Plates containing positive (bacteria with medium) and negative (bacteria with 10 mg/mL Streptomycin) controls for each bacterial species were also prepared. The lowest concentration of the extract at which no bacterial growth was observed was recorded as the MBC. The MBC experiments were performed in triplicate.
The inhibition data are presented as the percentage of the positive control +/− SD. The MIC values are the concentrations of each plant that were statistically significant (value of 0.001 or less) compared with the control samples.
Results and discussion
Juice prepared from unripe G. barbadense fruit exhibited more than 25% growth inhibition of the two Gram-positive bacteria S. aureus (ATCC 6341) and S. saprophyticus (ATCC 15305) relative to Streptomycin treatment which showed 100% inhibition at 5 mg/mL. S. aureus (ATCC 6341) has been isolated from the discharge produced during an otitis media infection, which provides a rationale for the use of G. barbadense juice (juice from the unripe fruit) as an herbal remedy for this infection . The antimicrobial activity was observed at a concentration of 7 mg/mL, the lowest concentration tested (Figure 1A). The MIC values that were determined in this study for G. barbadense against S. aureus (ATCC 6341) and S. saprophyticus (ATCC 15305) did not meet the p-value of 0.001 or less used in our analyses. This result contrasts with a study of medicinal plants from Yemen in which aqueous extracts from G. barbadense were not active (MIC values > 1,000 μg/mL) against S. aureus and E. coli and showed low activity (MIC = 1000 μg/mL) against P. aeruginosa and other bacterial strains . In our study, no measureable MBC was observed for either bacterial species. Treatment for otitis media using herbal remedies has been very difficult. A study using an ethanolic extract of the commonly used herb for infectious diseases, Echinacea purpurea roots and seeds, did not show a decrease in the risk of otitis media infection . Nevertheless, naphthofuran analogues and biologically active terpenoids from G. barbadense are known to exhibit growth-inhibitory and antibacterial activities [20, 21]. In addition, the essential oil has been reported to show moderate activities against S. aureus, E. coli and the fungus C. albicans. Although the antimicrobial activity in the oil might be due to the major components or to synergy between major and minor components of the oil, α-pinene, which is a terpene that comprises 12.8% of the oil, has shown efficient antimicrobial properties.
MIC (p-value 0.001 or less) and MBC of extracts that showed inhibition in the disc diffusion assays a
The decoction of T. ananassae at 15.3 mg/mL, the lowest concentration tested, inhibited the growth of two Gram-positive and two Gram-negative bacterial strains by 22%-30% compared to the 100% inhibition of Streptomycin at 5 mg/mL (Figure 1C). Specifically, the growth inhibition values of P. aeruginosa (ATCC 7700), S. saprophyticus (ATCC 15305), S. aureus (ATCC 6341) and P. vulgaris (ATCC 6896) were 29%, 22%, 32% and 24%, respectively. The MIC values for T. ananassae were 0.5 mg/mL for P. aeruginosa (ATCC 7700), and P. vulgaris (ATCC 6896) (p = 0.0002 and 0.0001, respectively), 0.015 mg/mL for S. aureus (ATCC 6341) (p = 0.001) and 2.0 mg/mL for S. saprophyticus (ATCC 15305) (p = 0.0004) (Table 2). T. ananassae displayed bactericidal activity against P. vulgaris (ATCC 6896) and S. saprophyticus (ATCC 15305) at concentrations of 2.0 mg/mL for both species (Table 2). Our study showed that T. ananassae inhibits the growth of pathogens associated with opportunistic infections of burns and skin infections such as P. aeruginosa and S. aureus, respectively . P. aeruginosa has become an important cause of infection, especially in immunocompromised patients, such as diabetic and cancer patients . The antibiotic activities of T. ananassae are important because people with diabetes are vulnerable to infections as a result of low blood flow to the extremities  and because of certain types of neuropathy that cause dry and cracked skin. Additional antimicrobial activity has been reported for T. ananassae against the Gram-negative bacterium Helicobacter pylori.
Decoctions of Syzygium jambos leaves inhibited S. aureus (ATCC 6341) and S. saprophyticus (ATCC 15305) by 34% and 11%, respectively, at the lowest concentration studied (10.5 μg/μL) relative to Streptomycin which showed 100% inhibition at 5 mg/mL. S. jambos at 20.9 mg/mL also inhibited the Gram-negative P. vulgaris (ATCC 6896) by 24% relative to Streptomycin which showed 100% inhibition at 5 mg/mL (Figure 1D). The MIC value for S. aureus (ATCC 6341) and S. saprophyticus (ATCC 15305) were 0.5 mg/mL (p = 0.00001 and 0.001, respectively), and the MIC value for P. vulgaris (ATCC 6896) was 0.031 mg/mL (p = 0.001) (Table 2). S. jambos was the only extract that showed bactericidal activity against all of the isolates that were tested. The MBC value for both S. aureus (ATCC 6341) and P. vulgaris (ATCC 6896) was 1.0 mg/mL, and the MBC value for S. saprophyticus (ATCC 15305) was 2.0 mg/mL (Table 2). Previously, Lin et al. reported that aqueous and acetone extracts from the bark of Syzygium jambos had activity against several species of S. aureus with MIC values that ranged from 0.50 to 0.75 mg/mL and suggested that more active inhibitory compounds are found in the leaves (0.21 to 0.83 mg/mL) than in the bark . Additionally, methanolic extracts of Syzygium aromaticum showed inhibition against S. aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Salmonella enterica serovar Typhi and P. aeruginosa with MICs ranging from 31.25-250 μg/mL . We did not find antimicrobial activity against P. aeruginosa, which suggests that variation in the polarities of the extraction solvents and the preparation methods used to make the extracts that were studied may account for the difference in the activities of these two species.
For nearly all of the plant species that have significant uses but that did not show antimicrobial activity, there is evidence that their activity varies significantly with the polarity and the concentration of the extracts, which in turn determines the phytochemicals responsible for the antibiotic effects [3, 34]. For instance, the antimicrobial effects of hydroalcoholic extracts from the leaves of Plectranthus amboinicus have been reported against S. aureus with a MIC of 9.3 mg/mL . In another study , seven out of ten S. aureus strains obtained from exudates of otitis externa were sensitive to P. amboinicus extracts at concentrations ranging from 1.25 to 5.0 mg/mL. In particular, the essential oil of P. amboinicus was active against two of the strains tested at 4% and 8% (w/V). This result is noteworthy because the decoction, which corresponds to the traditional preparation that is used, significantly resembles the fraction obtained from a steam distillation, which carries the essential oils that would have been inactive in solution at the concentrations obtained in this study (5.3 – 21.3 μg/μL). The authors do not report the polarity of the extracts, although the use of hydroalcoholic extracts was suggested.
The polar methanolic extracts from the leaves and bark of Aristolochia trilobata showed activity against E. coli with a MIC value of 2.5 mg/mL . This MIC value is comparable to the concentration of the decoctions tested in this study, which were 3.22 and 3.53 mg/mL for the stem and leaves, respectively. It is known that methanol extractions are more exhaustive than those of the aqueous or less polar organic and non-polar organic solvents. Therefore, the compounds that are responsible for the observed activity could be absent from the aqueous decoctions. However, the authors previously reported that the traditional use of this plant species has to be discouraged due to the mutagenic and possibly human carcinogenic properties of the aristolochic acids present in the methanol extracts and possibly in the water preparations of aerial parts of the plant.
Serrulatane quinonoid biflorin, which is isolated from the root tissue of Capraria biflora, has been reported to exhibit antimicrobial activities against Gram-positive bacteria . This activity is consistent with the traditional use to treat conjunctivitis, which may be associated with infections by S. aureus, S. epidermidis and Propionibacterium spp., among others. Thus far, the activity of aqueous extracts from the leaves has not been reported.
Aqueous extracts from the rhizomes of Costus speciosus have been reported to exhibit antimicrobial activity against S. aureus at a concentration of 200 mg/mL . The report describes the traditional system of administration studied herein, but given that the concentrations tested in our study varied from 11.8 – 47.3 μg/μL, a continuous administration of the decoction would be required to explain the traditional use for kidney infections.
Although there are several reports of the broad spectrum antimicrobial activity of Cucurbita moschata oil and seed extracts, no reports were found on the activity of decoctions from the leaves . Likewise, only ethanol and acetone:ethyl acetate (1:1) extracts of the aerial parts of H. rosa-sinensis have been studied previously [41, 42]. The reported MIC and MBC values for the ethanolic extract of the flowers against S. aureus were 20 mg/mL. Thus, although the activities reported indicate that antimicrobial compounds are present in more polar solvents, higher concentrations than that found in the traditional remedy are needed to assess the antibacterial activity.
The results for Plantago major are similar to those described above. That is, at a concentration of 2 mg/mL in the hydroalcoholic extract, which is higher than those found in the decoctions (7.2 – 28.7 μg/μL), the authors reported MIC values of 1 mg/mL for S. aureus and > 1 mg/mL against E. coli, P. aeruginosa, C. albicans and others . Furthermore, the antibacterial properties of lyophilized and fresh water extracts of Abelmoschus esculentus were effective against all bacterial strains tested, including S. aureus, E. coli and P. aeruginosa. The fresh extract displayed better antibacterial properties than the lyophilized extract . The MIC values for peeled and unpeeled A. esculentus were 6.4 and 12.8 mg/mL for S. aureus and P. aeruginosa, respectively. In this case, the lipid fraction of A. esculentus was found to be responsible for the antibacterial properties, whereas the protein and polysaccharide fractions displayed no antimicrobial activity. The concentration of the A. esculentus decoction that was prepared in this study according to the traditional use reported during the ethnopharmacological survey was 12.6 mg/mL.
This study did not find antimicrobial activity that validates the traditional use of several herbal decoctions that showed significant use during TRAMIL ethnopharmacological surveys. Two separate analyses, the disc diffusion and the MIC assays, demonstrated that fewer than 33% of the herbal remedies that were examined exhibited antibacterial activities. This result is not discouraging because several factors, in addition to those studied, could determine the effectiveness of the extracts. First, the extracts could contribute to the treatment of disease, not necessarily by exerting an antibacterial response but by promoting an anti-inflammatory response. This effect was shown by Yang and collaborators, who demonstrated the antimicrobial and anti-inflammatory properties of the essential oils from Citrus sunki. In addition, aqueous extracts are typically less potent formulations than those prepared with organic solvents such as methanol . The solvent and the extraction system may modify the final results as described in the study of Argemone mexicana. In this study, although the various solvent extracts examined were effective, the methanolic extracts showed maximum inhibition against the tested microorganisms, followed by hot aqueous extracts and cold aqueous extracts.
This study examined the inhibitory activity of Caribbean herbal remedies, which are treatments that are generally used by the surveyed populations for otitis media, kidney stones, skin burns, fever and conjunctivitis, which are associated with infections caused by Gram-positive and Gram-negative bacteria. Considering that antimicrobials are typically regarded as bactericidal if the MBC is nearly four times the MIC, this study identified the novel bactericidal properties of T. ananassae and S. jambos decoctions, which are commonly used as diabetes adjuvants in Puerto Rico. The bactericidal activities of these preparations will be extremely useful when treating patients with compromised immune systems, such as diabetes patients. Additionally, this article is the first report of the antimicrobial activities of G. barbadense and P. calomelanos decoctions. The findings that are reported here, which are the result of a screen for the antimicrobial activities of traditional Caribbean herbal remedies, will be presented to the TRAMIL program to inform future TRADIF activities.
The authors wish to thank all the families who participated in the ethnopharmacological surveys throughout the Caribbean region, the RISE Program at UPR-Cayey for their continued support to our research group, Mr. José Sustache, Director of the George Proctor Herbarium (SJ) and Mr. Héctor Serrano, Resident Biologist at Carite National Forest. This work was conducted with support from the Institute of Interdisciplinary Research at UPR-Cayey and the USA National Institutes of Health RIMI Program Grant #1-P2MD001112-0.
- Walsh FM, Amyes SG: Microbiology and drug resistance mechanisms of fully resistant pathogens. Curr Opin Microbiol. 2004, 7 (5): 439-444. 10.1016/j.mib.2004.08.007.View ArticlePubMedGoogle Scholar
- Cowan MM: Plant products as antimicrobial agents. Clin Microbiol Rev. 1999, 12: 564-582.PubMedPubMed CentralGoogle Scholar
- Coutinho HD, Costa JG, Lima EO, Falcão-Silva VS, Siqueira JP: Herbal therapy associated with antibiotic therapy: potentiation of the antibiotic activity against methicillin--resistant Staphylococcus aureus by Turnera ulmifolia L. BMC Complement Altern Med. 2009, 8 (9): 13-View ArticleGoogle Scholar
- Israr F, Hassan F, Naqvi BS, Azhar I, Jabeen S, Hasan SM: Report: Studies on antibacterial activity of some traditional medicinal plants used in folk medicine. Pak J Pharm Sci. 2012, 25 (3): 669-674.PubMedGoogle Scholar
- Helmer EH, Ramos O, del Mar López T, Díaz W: Mapping the forest type and land cover of Puerto Rico, a component of the Caribbean biodiversity hotspot. Caribbean Journal of Science. 2002, 38: 165-183.Google Scholar
- Germosén-Robineau L, Delens M, García-González M, Herrera J, Morón F, Sáenz-Campos D, Solís P: Farmacopea Vegetal Caribeña. 2005, Santo Domingo: Editora y Papelería Josué, 2Google Scholar
- Boulogne I, Germosén-Robineau L, Ozier-Lafontaine H, Fleury M, Loranger-Merciris G: TRAMIL Ethnopharmalogical survey in Les Saintes, Guadeloupe (French West Indies): a comparative study. J Ethnopharmacol. 2011, 133: 1039-1050. 10.1016/j.jep.2010.11.034.View ArticlePubMedGoogle Scholar
- Nuñez E: Plantas Medicinales de Puerto Rico. 1989, Río Piedras: Editorial de la Universidad de Puerto RicoGoogle Scholar
- Benedetti MD: Sembrando y sanando en Puerto Rico. 1996, Cayey: Verde LuzGoogle Scholar
- Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V: Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med. 1992, 1 (5): 281-287.PubMedGoogle Scholar
- Chao CY, Cheing GL: Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev. 2009, 25 (7): 604-614. 10.1002/dmrr.1004.View ArticlePubMedGoogle Scholar
- De Bona KS, Bellé LP, Bittencourt PE, Bonfanti G, Cargnelluti LO, Pimentel VC, Ruviaro AR, Schetinger MR, Emanuelli T, Moretto MB: Erythrocytic enzymes and antioxidant status in people with type 2 diabetes: beneficial effect of Syzygium cumini leaf extract in vitro. Diabetes Res Clin Pract. 2011, 94 (1): 84-90. 10.1016/j.diabres.2011.06.008.View ArticlePubMedGoogle Scholar
- Rivero-Cruz JF: Antimicrobial compounds isolated from Haematoxylon brasiletto. J Ethnopharmacol. 2008, 119 (1): 99-103. 10.1016/j.jep.2008.06.005.View ArticlePubMedGoogle Scholar
- UofMHealth.org: US hospitals are all over the map when it comes to preventing the most common type of in-hospital infection. 2008,http://www.uofmhealth.org/node/666938,Google Scholar
- BSAC: Methods for Bacterial Susceptibility Testing (Version 7). 2010,http://bsac.org.uk/wp-content/uploads/2012/02/version_7.pdf,Google Scholar
- Velmonte M, Gonzaga A, Darvin C: Local production of Low cost quality antibiotic susceptibility disks for the Philippines. Phil J Microbiol Infect Diseases. 1988, 17 (2): 66-75.Google Scholar
- Abera B, Biadeglegne F: Antimicrobial resistance patterns of staphylococcus aureus and Proteus spp. Isolated from otitis media at bahir Dar regional laboratory, north west Ethiopia. Ethiop Med J. 2009, 47 (4): 271-276.PubMedGoogle Scholar
- Al-Fatimi M, Wurster M, Schröder G, Lindequist U: Antioxidant, antimicrobial and cytotoxic activity of selected medicinal plants from Yemen. J Ethnopharmacol. 2007, 111: 657-666. 10.1016/j.jep.2007.01.018.View ArticlePubMedGoogle Scholar
- Wahl RA, Aldous MB, Worden KA, Grant KL: Echinacea purpurea and osteopathic manipulative treatment in children with recurrent otitis media: a randomized controlled trial. BMC Complement Altern Med. 2008, 8: 56-10.1186/1472-6882-8-56.View ArticlePubMedPubMed CentralGoogle Scholar
- Kanlayavattanakul M, Lourith N: Therapeutic agents and herbs in topical application for acne treatment. Int J Cos Sci. 2011, 3: 289-297.View ArticleGoogle Scholar
- KirilmiŞ C, Koca M, Servi S, Gür S: Synthesis and antimicrobial activity of Dinaphtho[2,1-b]furan-2-yl-methanone and their oxime derivatives. Turk J Chem. 2009, 33: 375-384.Google Scholar
- Essien EE, Aboaba SO, Ogunwande IA: Constituents and antimicrobial properties of the leaf essential oil of Gossypium barbadense (Linn.). J Med Plant Res. 2011, 5: 702-705.Google Scholar
- Furuhata M, Iwamura M, Baba S, Inoue M: Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty. Int J Urol. 2004, 10 (4): 228-230.View ArticleGoogle Scholar
- Shokeen P, Bala M, Tandon V: Evaluation of the activity of 16 medicinal plants against Neisseria gonorrhoeae. Int J Antimicrob Agents. 2009, 33 (1): 86-91. 10.1016/j.ijantimicag.2008.07.022.View ArticlePubMedGoogle Scholar
- Khan MR, Omoloso AD: Antibacterial and antifungal activities of angiopteris evecta. Fitoterapia. 2008, 79 (5): 366-369. 10.1016/j.fitote.2008.02.007.View ArticlePubMedGoogle Scholar
- Souza TM, Morais-Braga MFB, Costa JGM, Saraiva AAF, Coutinho HDM: Enhancement of antimicrobial activity of antibiotics and antifungals by the use of natural products from pityrogramma calomenanos (L.) link. Arch. Biol. Sci. 2012, 64: 43-48. 10.2298/ABS1201043S.View ArticleGoogle Scholar
- Mithraja MJ, Antonisamy JM, Mahesh M, Paul ZM, Jeeva S: Chemical diversity analysis on some selected medicinally important pteridophytes of Western Ghats, India. Asian Pacific J Trop Biomed. 2012, 2 ((Suppl 1)): S34-S39.View ArticleGoogle Scholar
- Church D, Elsayed S, Reid O, Winston B, Lindsay R: Burn wound infections. Clin Microbiol Rev. 2006, 19: 403-434. 10.1128/CMR.19.2.403-434.2006.View ArticlePubMedPubMed CentralGoogle Scholar
- Varaiya A, Kulkarni M, Bhalekar P, Dogra J: Incidence of carbapenem-resistant pseudomonas aeruginosa in diabetes and cancer patients. Indian J Med Microbiol. 2008, 26 (3): 238-240. 10.4103/0255-0857.42033.View ArticlePubMedGoogle Scholar
- Nielson DL, Ali Y: Diabetic foot infections: time to change the prognostic concept. J Am Podiatr Med Assoc. 2009, 99 (5): 454-458.View ArticlePubMedGoogle Scholar
- Ndip RN, Malange Tarkang AE, Mbullah SM, Luma HN, Malongue A, Ndip LM, Nyongbela K, Wirmum C, Efange SM: In vitro anti-Helicobacter pyroli activity of extracts of selected medicinal plants from North West Cameroon. J Ethnopharmacol. 2007, 114 (3): 452-457. 10.1016/j.jep.2007.08.037.View ArticlePubMedGoogle Scholar
- Lin WH, Chang ST, Chang SC, Chang HT: Isolation of antibacterial diterpenoids from Cryptomeria japonica bark. Nat Prod Res. 2008, 22: 1085-1093. 10.1080/14786410802267510.View ArticleGoogle Scholar
- Ali NH, Faizi S, Kazmi SU: Antibacterial activity in spices and local medicinal plants against clinical isolates of Karachi. Pharm Biol. 2011, 49 (8): 833-839. 10.3109/13880209.2010.551136.View ArticlePubMedGoogle Scholar
- Tiwari P, Kumar B, Kaur M, Kaur G, Kaur H: Phytochemical screening and extraction: a review. Int Pharma Sci. 2011, 1: 98-106.Google Scholar
- Gurgel APAD, da Silva JG, Grangeiro ARS, Xavier HS, Oliveira RAG, Pereira MSV, de Souza IA: Antibacterial effects of Plectranthus amboinicus (Lour.) Spreng (Lamiaceae) in Methicillin resistant Staphylococcus aureus (MRSA). Lat Am J Pharm. 2009, 28: 460-464.Google Scholar
- Nogueira JCR, Melo-Diniz MF, Lima EO: In vitro antimicrobial activity of plants in acute otitis externa. Rev Bras Otorrinolaringol. 2008, 74: 118-124. 10.1590/S0034-72992008000100019.View ArticleGoogle Scholar
- Camporese A, Balick MJ, Arvigo R, Esposito RG, Mordellino N, De Simone F, Tubaro A: Screening of anti-bacterial activity of medicinal plants from Belize (Central America). J Ethnopharmacol. 2003, 87: 103-107. 10.1016/S0378-8741(03)00115-6.View ArticlePubMedGoogle Scholar
- Smith JE, Tucker D, Watson K, Jones GL: Identification of antibacterial constituents from the indigenous Australian medicinal plant Eremophila duttonii F. Muell. (Myoporaceae). J Ethnopharmacol. 2007, 112: 386-393. 10.1016/j.jep.2007.03.031.View ArticlePubMedGoogle Scholar
- Saraf A: Phytochemical and antimicrobial studies of medicinal plant Costus speciosus (Koen.). E-J.Chem. 2010, 7 (S1): S405-S413. 10.1155/2010/605735.View ArticleGoogle Scholar
- Caili F, Huan S, Quanhong L: A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Human Nutr. 2006, 61: 73-80.View ArticleGoogle Scholar
- Seyyednejad SM, Koochak H, Darabpour E, Motamedi H: A survey on Hibiscus rosa-sinensis, Alcea rosea L. and Malva neglecta Wallr as antibacterial agents. Asian Pacific J Trop Med. 2010, 3: 351-355. 10.1016/S1995-7645(10)60085-5.View ArticleGoogle Scholar
- Facey PC, Pascoe KO, Porter RB, Jones AD: Investigation of plants used in Jamaican folk medicine for anti-bacterial activity. J Pharm Pharmacol. 1999, 51: 1555-1560.View ArticleGoogle Scholar
- Holetz FB, Pessini GL, Sanches NR, Garcia-Cortez DA, Nakamura CV, Dias-Filho BP: Screening of some plants used in the brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz. 2002, 97: 1027-1031. 10.1590/S0074-02762002000700017.View ArticlePubMedGoogle Scholar
- De Carvalho CCCR, Almeida-Cruz P, da Fonseca MMR, Xavier-Filho L: Antibacterial properties of the extract of Abelmoschus esculentus. Biotechnol Bioprocess Engineer. 2011, 16: 971-977. 10.1007/s12257-011-0050-6.View ArticleGoogle Scholar
- Yang EJ, Kim SS, Moon JY, Oh TH, Baik JS, Lee NH, Hyun CG: Inhibitory effects of Fortunella japonica var. margarita and Citrus sunki essential oils on nitric oxide production and skin pathogens. Acta Microbiol Immunol Hung. 2010, 57 (1): 15-27. 10.1556/AMicr.57.2010.1.2.View ArticlePubMedGoogle Scholar
- Parekh J, Karathia N, Chanda S: Screening of some traditionally used medicinal plants for potential antibacterial activity. Indian J Pharm Sci. 2006, 68 (6): 832-834. 10.4103/0250-474X.31031.View ArticleGoogle Scholar
- Bhattacharjee I, Chatterjee SK, Chatterjee S, Chandra G: Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria. Mem Inst Oswaldo Cruz. 2006, 101: 645-648.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/126/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.